Iodine intake and incidence of thyroid cancer in Denmark

被引:39
作者
Sehestedt, Thomas
Knudsen, Nils
Perrild, Hans
Johansen, Christoffer
机构
[1] Glostrup Cty Hosp, Dept Internal Med, DK-2200 Copenhagen, Denmark
[2] Univ Copenhagen, Bispebjerg Hosp, Dept Internal Med, DK-1168 Copenhagen, Denmark
[3] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark
关键词
D O I
10.1111/j.1365-2265.2006.02580.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Iodine intake is suspected to be a risk factor for thyroid cancer. Eastern Denmark is characterized by mild and western Denmark by moderate iodine deficiency, and this difference is associated with a 50% difference in the occurrence of goitre and thyrotoxicosis. The objective of the study was to determine whether the incidence of thyroid cancer differs between these two regions, as any difference would have important safety implications for the national iodine supplementation programme. Design and Methods We studied all thyroid cancers notified to the Danish Cancer Registry in the period 1973-1997, focusing on the four most frequent subtypes: papillary, follicular, anaplastic and medullary thyroid cancer. A Poisson regression model was used with models of goodness-of-fit for age, period, sex. Results No regional difference was found in the overall incidence of follicular (0.3% 100 000 person-years) or papillary (0.7% 100 000 person-years) thyroid cancer. A slight but nonsignificant increase in total incidence, resulting mainly from a significant increase in the incidence for the papillary subtype, was observed in both regions. Conclusion The results suggest that modest differences in iodine intake do not affect thyroid cancer incidence or the distribution of subtypes.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 40 条
[1]  
[Anonymous], 1980, Foundations of epidemiology
[2]   Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country [J].
BacherStier, C ;
Riccabona, G ;
Totsch, M ;
Kemmler, G ;
Oberaigner, W ;
Moncayo, R .
THYROID, 1997, 7 (05) :733-741
[3]  
BUBENHOFER R, 1997, SCHWEIZERISCHE MED W, V107, P731
[4]   The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency [J].
Burgess, JR ;
Dwyer, T ;
McArdle, K ;
Tucker, P ;
Shugg, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (04) :1513-1517
[5]   SERUM THYROID-HORMONE AND THYROTROPIN LEVELS IN SUBJECTS FROM ENDEMIC GOITER REGIONS OF NEW-GUINEA [J].
CHOPRA, IJ ;
HERSHMAN, JM ;
HORNABROOK, RW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (02) :326-333
[6]   Iodine and Cancer [J].
Feldt-Rasmussen, U .
THYROID, 2001, 11 (05) :483-486
[7]   Case-control study of thyroid cancer in Northern Italy: attributable risk [J].
Fioretti, F ;
Tavani, A ;
Gallus, S ;
Franceschi, S ;
Negri, E ;
La Vecchia, C .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1999, 28 (04) :626-630
[8]  
FORTNER J, 1969, CANCER, V66, P364
[9]   A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases [J].
Franceschi, S ;
Preston-Martin, S ;
Maso, LD ;
Negri, E ;
La Vecchia, C ;
Mack, WJ ;
McTiernan, A ;
Kolonel, L ;
Mark, SD ;
Mabuchi, K ;
Jin, F ;
Wingren, G ;
Galanti, R ;
Hallquist, A ;
Glattre, E ;
Lund, E ;
Levi, F ;
Linos, D ;
Ron, E .
CANCER CAUSES & CONTROL, 1999, 10 (06) :583-595
[10]   Iodine intake and thyroid carcinoma - A potential risk factor [J].
Franceschi, S .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 :S38-S44